Pancreatic Cancer Research

ResearcherGemeinschaftskrankenhaus HavelhöheNo recent work listed

Friedemann Schad

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-6928-6209; OpenAlex author ID A5067665323.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 0, last author 3)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy? Last author DOI 10.3390/cancers15041116↗
  2. Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer. Last author DOI 10.1155/2020/3543568↗
  3. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. Last author DOI 10.1186/s12885-016-2594-5↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Shiao Li Oei · 1 shared paper, 2023
  2. Anja Thronicke · 1 shared paper, 2020
  3. Jan Axtner · 1 shared paper, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.